Covid-19: management of exposed healthcare workers and patients in hospital settings –  Public Health England 
This guidance covers staff exposures; staff return to work criteria; and patient exposures.

COVID-19 – guidance for acute settings, Association of Paediatric Emergency Medicine (APEM); 2020.
This provides guidance for paediatric emergency and acute settings. It has been produced with the Association of Paediatric Emergency Medicine (APEM) and the British Paediatric Allergy, Immunity and Infection Group (BPAIIG). The guidance includes preparations, good practice tips, infection control, management of suspected cases in ED and as inpatients, plus advice and guidance on critical care scenarios.

NICE – Rapid Guidelines

• community-based care of patients with chronic obstructive pulmonary disease (COPD)
• dermatological conditions treated with drugs affecting the immune response
• cystic fibrosis
• critical care in adults
• managing symptoms (including at the end of life) in the community
• managing suspected or confirmed pneumonia in adults in the community
• dialysis service delivery
• delivery of radiotherapy
• delivery of systemic anticancer treatments.
• haematopoietic stem cell transplantation
• rheumatological autoimmune, inflammatory and metabolic bone disorders
• severe asthma

NICE – Evidence Summaries

• acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19

NEWS2 and deterioration in COVID-19 – Royal College of Physicians
This guidance emphasises the place of NEWS2 in managing patients with COVID-19.

Clinical guide for the management of critical care for adults with COVID-19 during the coronavirus pandemic – NHS England, 8 April 2020 Version 2
This clinical guidanceprovides contemporary information on the care of critically ill adultpatients with COVID-19 to practising clinicians at the bedside.

Clinical guide for the management of Rheumatology patients during the coronavirus pandemic – NHS England

Many these patients are at increased risk of coronavirus (CV) due to immunosuppression and underlying disease/related comorbidities. This guidanceadvises local solutions should be implemented to continue proper management of these patients while protecting resources for response to CV.

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) – A JAMA Review
The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented challenge to identify effective drugs for prevention and treatment. Given the rapid pace of scientific discovery and clinical data generated by the large number of people rapidly infected by SARS-CoV-2, clinicians need accurate evidence regarding effective medical treatments for this infection.

MindEd Covid-19 Resilience Hub
Helping front line staff in the NHS and care services manage your own mental health and wellbeing, whilst looking after others during the Covid-19 crisis. We have drawn together the best advice, tips, from our large panel of international experts to guide you and your team. Created on behalf of Health Education England in partnership with NHS England-Improvement. Supported by Skills For Care, this Hub is for everyone on the front line health and care services.

Policy paper: NHS debt write-off: regional breakdown – Department of Health and Social Care
Details of the £13.4 billion debt that will be written off to support the NHS in its response to coronavirus (COVID-19) and ensure long-term financial sustainability.

Coronavirus status checker – Department of Health and Social Care
People with potential coronavirus symptoms are now being asked to complete this status checkerand answer a short series of questions which will tell the NHS about their experience. It is designed help the NHS co-ordinate its response and build up additional data on the Covid outbreak.  Anyone in the United Kingdom can use the checker on the NHS website and in its initial phase the NHS is particularly keen for anyone who thinks they may be displaying potential coronavirus symptoms, no matter how mild, to complete it.

Online community involvement in Covid-19 research and outbreak response: early insights from a UK perspective – Imperial College London
Findings from online surveys of members of the public, carried out by the Patient Experience Research Centre, reveal that ineffective communication (including access to information and misinformation) are key concerns for the public, while vaccine development was considered the most urgent research priority. This report is the latest in a series to be released by Imperial’s Covid-19 Response Team.

Covid-19 health workforce estimator – World Health Organization
This planning toolaims to help countries to visualize and estimate the health workforce necessary for acute and intensive care over the course of the pandemic, and to project the timing and severity of the peak of the outbreak. The toolkit will assist countries in estimating the numbers of health workers needed based on projected numbers of moderate, severe and critical patients per day. This understanding of the potential workload from Covid-19 will also allow countries to anticipate and better address the mental health care needs of health workers.

Leading through Covid-19: supporting health and care leaders in unprecedented times –  The King’s Fund
The health and care system in the United Kingdom is facing a huge challenge, placing enormous pressure on health and care staff with unprecedented demands on leaders, wherever they work. These pages on The King’s Fund website aim to provide support to health and care leaders, whether they are working in the NHS, social care, public health or the voluntary and independent sector. We want to ensure this  support is  practical, helpful and works, so please use the online form to tell us how we can help. There’s also the first of our quick-read practical guides and videos.

Recessions and health: the long-term health consequences of responses to coronavirus – Institute for Fiscal Studies
This briefingnote outlines how worsening economic conditions and disruptions to NHS services could have important and far-reaching consequences for the health of the broader population. The coronavirus pandemic is putting the NHS under unprecedented strain and leading to cancelled operations and disruptions to non-coronavirus emergency care. The briefing concludes that this will disproportionately affect older individuals, and those from less affluent backgrounds, both in the short and the medium term.

Statistics

• Critical Care Bed Capacity and Urgent Operations Cancelled for February 20209 April 2020
• Integrated Urgent Care Aggregate Data Collection (IUC ADC) for February 2020
• Referral to treatment waiting times statistics for consultant-led elective care for February 2020
• Delayed Transfers of Care for February 2020
• Waiting times for suspected and diagnosed cancer patients for February 2020
• A&E attendances and emergency admissions for March 2020 and Quarterly report (Q4)
• Mixed-Sex Accommodation Breaches for February 2020
• NHS 111 Minimum Dataset for March 2020
• Diagnostic waiting times and activity for February 2020
• Monthly hospital activity data for February 2020
• Potential Coronavirus (COVID-19) symptoms reported through NHS Pathways and 111 online
• Provisional Accident and Emergency Quality Indicators for England – February 2020, by provider
• Provisional Monthly Hospital Episode Statistics for Admitted Patient Care, Outpatient and Accident and Emergency data – April 2019 – February 2020
• Psychological Therapies: reports on the use of IAPT services, England – January 2020 Final including reports on the IAPT pilots
• Summary Hospital-level Mortality Indicator (SHMI) – Deaths associated with hospitalisation, England, December 2018 – November 2019